UNION KOREA PHARM Amends Capital Reduction Completion Filing - Fractional Share Cancellation Count Adjusted by 1 Share, No Change to Financial Impact

This amendment corrects a minor clerical error in the capital reduction completion disclosure filed on July 1, 2026, adjusting the number of fractional shares cancelled from 3,706 to 3,705.
The correction has no material impact on financial statements or capital structure, and the previously disclosed dilution effect from the capital reduction and subsequent capital increase remains unchanged.
Currently, total outstanding shares stand at 79,854,006 with a capital of 39,927,003,000 KRW, reflecting the completion of the third-party allotment capital increase.
[AI Summary]This amendment is an administrative rectification of a typographical error and does not affect investment decisions. The previously disclosed shareholder dilution risk from the rehabilitation plan's capital reduction and capital increase remains valid.